Question

I am a breastfeeding mother and i want to know if it is safe to use 1-Diethylcarbamoyl-4-methylpiperazine dihydrogen citrate? Is 1-Diethylcarbamoyl-4-methylpiperazine dihydrogen citrate safe for nursing mother and child? Does 1-Diethylcarbamoyl-4-methylpiperazine dihydrogen citrate extracts into breast milk? Does 1-Diethylcarbamoyl-4-methylpiperazine dihydrogen citrate has any long term or short term side effects on infants? Can 1-Diethylcarbamoyl-4-methylpiperazine dihydrogen citrate influence milk supply or can 1-Diethylcarbamoyl-4-methylpiperazine dihydrogen citrate decrease milk supply in lactating mothers?

1-Diethylcarbamoyl-4-methylpiperazine dihydrogen citrate lactation summary

1-Diethylcarbamoyl-4-methylpiperazine dihydrogen citrate usage has low risk in breastfeeding
  • DrLact safety Score for 1-Diethylcarbamoyl-4-methylpiperazine dihydrogen citrate is 3 out of 8 which is considered Low Risk as per our analyses.
  • A safety Score of 3 indicates that usage of 1-Diethylcarbamoyl-4-methylpiperazine dihydrogen citrate may cause some minor side effects in breastfed baby.
  • Our study of different scientific research indicates that 1-Diethylcarbamoyl-4-methylpiperazine dihydrogen citrate may cause moderate to no side effects in lactating mother.
  • Most of scientific studies and research papers declaring usage of 1-Diethylcarbamoyl-4-methylpiperazine dihydrogen citrate low risk in breastfeeding are based on normal dosage and may not hold true for higher dosage.
  • While using 1-Diethylcarbamoyl-4-methylpiperazine dihydrogen citrate We suggest monitoring child for possible reactions. It is also important to understand that side effects vary largely based on age of breastfed child and time of medication in addition to dosage.
  • Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.

Answer by Dr. Ru: About 1-Diethylcarbamoyl-4-methylpiperazine dihydrogen citrate usage in lactation

Used in the treatment of filaria, loa, mansonella and toxocara infection. Not longer recommended for onchocerciasis. Dosage for children is available. Periodic treatment strategies for entire populations have been undertaken (not recommended for newborns). Diethylcarbamazine enriched salt has been used. Check-up for untoward effects related to the drug itself which are usually mild and parasite killing dependent. Not commercially available in Spain.

Alternate Drugs for Anthelmintic

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.